Pay in 4 interest-free payments of $6.54 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Novo Nordisk announced FDA acceptance of their New Drug Application (NDA) for a 25 mg oral version of Wegovy for two new indications: (1) chronic weight management in adults living with obesity or who are overweight with at least one comorbid condition, and (2) to reduce the risk of MACE in adults with overweight or obesity and established CVD
Analyze bulk pricing tiers and Minimum Order Quantities (MOQ) relative to your production scale
A small, thin needle
doi: Seiwerth S, Brcic L, Vuletic L, et al
The FDA is currently evaluating whether GLP-1 medications may increase the risk of suicidal thoughts or actions
Frontiers in Psychiatry, 9, 44
US$ 21.41
US$ 26.38
US$ 27.91
US$ 23.75
US$ 21.66
US$ 21.89
US$ 29.47
